0 votes
18 views
ago in General Health by (570 points)
Is T-cell therapy last resort?

1 Answer

0 votes
ago by (11.7k points)
No, T-cell therapy is not always last resort, although T-cell therapy was historically used as a last resort.

T-cell therapy like CAR T-cell therapy is not used strictly as a last resort today like it used to be.

Car T-cell therapy was initially approved only after multiple prior treatments, like chemotherapy and stem cell transplants, had failed or had stopped working, which then made T-cell therapy like Car T-cell therapy a final option for people that had few other options.

However, now clinical guidelines as well as FDA approvals have evolved.

And for certain blood cancers such as specific types of leukemia and lymphoma cancers, T-cell therapy is now increasingly being moved up to earlier lines of cancer treatment options, and sometimes even as an early relapse option or even being evaluated in initial cancer treatment settings.

Oncologists also often prefer to refer and treatment cancer patients while they are still relatively stable, rather than waiting until they are exhausted by the use of multiple toxic therapies for their cancer treatments.

Although, availability of T-cell therapy can still be limited by specific disease indications, insurance criteria as well as manufacturing slots.

CAR T-cell therapy, also known as "chimeric antigen receptor T-cell therapy" is an advanced type of immunotherapy that re-engineers your own white blood cells—specifically T cells—to hunt down and destroy cancer cells.

Car T-cell therapy works by the following mechanisms.

1. Cell Collection: T cells are extracted from the patient's blood using a process called apheresis.

2. Genetic Modification: In a laboratory, scientists insert a new gene into the T cells.

This gene codes for a special protein called a chimeric antigen receptor (CAR), which allows the T cells to recognize and bind to specific proteins (antigens) on the surface of cancer cells.

3. Multiplication: The modified CAR T cells are grown and multiplied in the lab until there are millions of them.

4. Infusion: The cells are infused back into the bloodstream, where they seek out, attach to, and destroy the cancer cells.

They can also remain in the body long-term to help prevent a relapse.

The cancers that Car T-cell therapy treats include:

Blood Cancers: Car T-cell therapy is approved by the FDA for certain types of leukemia (such as acute lymphoblastic leukemia), lymphomas (such as non-Hodgkin lymphoma), and multiple myeloma.

Solid Tumors: Researchers are actively studying how to adapt CAR T-cell therapy for solid tumors, though it is more complex due to the protective environment around those tumors.

Common Side Effects of Car T-cell therapy include:

Cytokine Release Syndrome (CRS): A system-wide immune response causing high fevers, chills, fatigue, and low blood pressure.

Neurological Symptoms: Confusion, headaches, or difficulty speaking.

Increased Risk of Infection: The therapy can lower normal blood cell or antibody counts.

2.5k questions

2.5k answers

22 comments

141 users

VekDrive.com Cloud Storage and File Sharing.

Get 5 GB Free Cloud Storage when you signup for a free account.

Or get 50 GB of Cloud Storage for $3.00 per month.

VekDrive Cloud Storage

...